Search clinical trials for: Valganciclovir Hydrochloride

Total 7449 results

Laureate Institute for Brain Research, Inc.

Recruiting

ANTIVIRAL TREATMENT OF CYTOMEGALOVIRUS IN DEPRESSION

Major Depressive Disorder

United States
Heidelberg ImmunoTherapeutics GmbH

Completed

Monoclonal Antibody Therapy Against Chronic Herpes Simplex Virus 2 Infection (MATCH-2)

Herpes Genitalis

Germany
Nuria Lloberas
Ministerio de Sanidad, Servicios Sociales e Igualdad

Completed

Individualization of Ganciclovir and Valganciclovir Doses Using Bayesian Prediction in Renal Transplant Patients.

Infection in Solid Organ Transplant Recipients

Spain
Viracta Therapeutics, Inc.

Completed

Dose Escalation & Expansion Study of Oral VRx-3996 & Valganciclovir in Subjects With EBV-Associated Lymphoid Malignancies

Lymphoproliferative Disorders | Epstein-Barr Virus Associated Lymphoma

United States, Brazil
Shire
Takeda Development Center Americas, Inc.

Completed

A Study of Maribavir Compared to Valganciclovir to Treat Cytomegalovirus Infections in People Who Have Received Stem Cell Transplants

Cytomegalovirus (CMV)

United States, China, Spain, Belgium, Australia, Germany, Italy, Canada, France, Croatia, Singapore, United Kingdom, New Zealand, Korea, Republic of, Russian Federation, Poland, Austria, Greece, Switzerland, Czechia, Hungary, Israel, Turk...
Dr. Ann C.T.M. Vossen
Leiden University Medical Center; Stichting Nuts Ohra

Completed

Congenital Cytomegalovirus: Efficacy of Antiviral Treatment (CONCERT 2)

Sensorineural Hearing Loss | Congenital Cytomegalovirus Infection

Netherlands
Hoffmann-La Roche

Completed

A Study on Spermatogenesis in Male Renal Transplant Recipients Receiving Valganciclovir (Valcyte®) Versus Untreated Matched Controls

Cytomegalovirus Infections

United States, Mexico
Hadassah Medical Organization

Completed

Valganciclovir in Prevention of Cytomegalovirus (CMV) Reactivation Following Allogeneic-Stem Cell Transplantation (SCT)

Cytomegalovirus | Bone Marrow Transplantation

Israel
Hospital Universitari de Bellvitge
Instituto de Salud Carlos III; Spanish Society of Cardiology

Recruiting

Multicenter Clinical Trial to Evaluate the Efficacy of a Preventive Strategy Against CMV Infection in Heart Transplant Patients, Based on the Specific T Cells Response (ELISPOT-TC)

CMV Infection | Heart Transplant Infection

Spain
National Institute of Allergy and Infectious Diseases...

Completed

Valganciclovir Therapy in Infants and Children With Congenital CMV Infection and Hearing Loss

Cytomegalovirus Infection

United Kingdom, United States
National Institute of Allergy and Infectious Diseases...

Completed

Short-Term vs. Long-Term Valganciclovir Therapy for Symptomatic Congenital CMV Infections

Cytomegalovirus Infection

United Kingdom, United States
Medical University of South Carolina
Takeda

Recruiting

Maribavir vs. Valganciclovir for CMV Prophylaxis in High-Risk Kidney Transplant Recipients

CMV | Transplant Complication

United States
Centre Hospitalier Universitaire de Saint Etienne
Ministry of Health, France

Terminated

Impact of Anti-cytomegalovirus Treatment in the Management of Relapsing Ulcerative Colitis Requiring Vedolizumab Therapy (CYTOVEDO)

Ulcerative Colitis, Unspecified

France
Chimerix

Terminated

A Phase 3 Study of Brincidofovir Versus Valganciclovir for the Prevention of Cytomegalovirus

Kidney Transplant Infection | Cytomegalovirus Disease

United States
Dr. Ann C.T.M. Vossen
Leiden University Medical Center; Stichting Nuts Ohra

Terminated

Congenital Cytomegalovirus: Efficacy of Antiviral Treatment in a Randomized Controlled Trial (CONCERT)

Sensorineural Hearing Loss | Congenital Cytomegalovirus Infection

Netherlands
National Cancer Institute (NCI)

Completed

Tocilizumab for KSHV-Associated Multicentric Castleman Disease

Castleman Disease | Multicentric Castleman Disease | Giant Lymph Node Hyperplasia

United States
Rznomics, Inc.

Not yet recruiting

A Study to Evaluate the Safety, Tolerability and Efficacy of RZ-001 With Valganciclovir (VGCV) in Subjects With Glioblastoma

Glioblastoma
Medical University of South Carolina
CSL Behring

Completed

Cytogam Administration in Abdominal Organ Transplant Recipients at High Risk for Cytomegalovirus Infection

Cytomegalovirus Disease

United States
Chimerix

Terminated

A Phase 3 Study of Brincidofovir Versus Valganciclovir for the Prevention of Cytomegalovirus Disease (SUSTAIN)

Cytomegalovirus Disease

United States
M.D. Anderson Cancer Center
Roche Pharma AG

Completed

Oral Valganciclovir Versus Valacyclovir

Leukemia | Chronic Lymphocytic Leukemia

United States
National Institute of Cancerología
Instituto Nacional de Enfermedades Respiratorias

Completed

Impact of Valganciclovir on Severe IRIS-Kaposi Sarcoma Mortality: an Open-label, Parallel, Randomized Controlled-trial.

Kaposi Sarcoma | Human Immunodeficiency Virus | Immune Reconstitution Syndrome

Mexico
GlaxoSmithKline

Completed

A Safety And Tolerability Study Of Valaciclovir Oral Suspension In Infants And Children

Herpes Simplex

United States, Chile, South Africa
National Institute of Allergy and Infectious Diseases...

Completed

Valaciclovir to Prevent Transmission of Herpes Simplex Virus

Herpes Simplex

United States
HemaQuest Pharmaceuticals Inc.

Terminated

Study of HQK-1004 and Valganciclovir to Treat Epstein-Barr Virus (EBV) - Positive Lymphoid Malignancies or Lymphoproliferative Disorders

Lymphoproliferative Disorders | Lymphoid Malignancies

United States
Vanderbilt University Medical Center
Genentech, Inc.

Completed

A Pilot Trial of Herpesvirus Treatment in Idiopathic Pulmonary Fibrosis (IPF)

Idiopathic Pulmonary Fibrosis

United States
University of Lausanne Hospitals

Completed

Cell-mediated Immunity for Prevention of CMV Disease

Cytomegalovirus Infections

Switzerland
Mepha Ltd.

Completed

Efficacy and Safety of Nitrofurantoin in the Treatment of Uncomplicated Urinary Tract Infections in Adults

Urinary Tract Infection

Mexico
Hospital Universitario 12 de Octubre
Institut National de la Santé Et de la Recherche Médicale, France; University... and other collaborators

Active, not recruiting

Empirical Treatment Against Cytomegalovirus and Tuberculosis in HIV-infected Infants With Severe Pneumonia (EMPIRICAL)

Pneumonia | HIV/AIDS | Tuberculosis | Cytomegalovirus Infections

Zimbabwe, France, Côte D'Ivoire, Italy, Malawi, Mozambique, Netherlands, Spain, Uganda, United Kingdom, Zambia
Albert Park
Genentech, Inc.; National Institute on Deafness and Other Communication Disorders...

Active, not recruiting

Randomized Controlled Trial of Valganciclovir for Cytomegalovirus Infected Hearing Impaired Infants (ValEAR)

Cmv Congenital | CMV | Congenital Cmv | SNHL | Sensorineural Hearing Loss

United States
Academisch Medisch Centrum - Universiteit van Amsterdam...

Recruiting

Improving Outcome in Subarachnoid Hemorrhage wIth Nadroparine (ISCHEMIA)

Delayed Cerebral Ischemia | Aneurysmal Subarachnoid Hemorrhage

Netherlands
GlaxoSmithKline

Completed

Evaluation Of Valaciclovir In Patients With Chickenpox

Varicella
GlaxoSmithKline

Completed

A Study Comparing Daily Treatment With Valaciclovir To Placebo For Suppression Of Herpes Simplex Virus HSV-2 Genital Herpes In Newly Diagnosed Patients. VALTREX® Tablet is a Trademark of the GlaxoSmithKline Group of Companies.

Herpes Genitalis

United States, Canada, Brazil, Argentina, Chile
Maruho Co., Ltd.

Completed

Phase III Study of ASP2151 in Herpes Zoster Patients

Herpes Zoster

Japan
GlaxoSmithKline

Completed

VALTREX Once Daily For Viral Shedding In Herpes Simplex Virus 2 (HSV-2) Seropositive Subjects. VALTREX® Tablet is a Trademark of GlaxoSmithKline Group of Companies.

Infections, Herpesviridae

United States
GlaxoSmithKline

Completed

Special Drug Use Investigation for VALTREX (Valaciclovir) (Pediatrics Chickenpox)

Varicella
City of Hope Medical Center
National Cancer Institute (NCI)

Suspended

Copanlisib and Venetoclax for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma

Recurrent Mantle Cell Lymphoma | Refractory Mantle Cell Lymphoma

United States
Hugo Lovheim

Completed

Feasibility and Effects of Valaciclovir Treatment in Persons With Early Alzheimer's Disease (VALZ-Pilot)

Alzheimer Disease | Herpes Simplex | Mild Cognitive Impairment

Sweden
Professor Lorraine Harper
Wellcome Trust

Unknown

CMV Modulation of the Immune System in ANCA-associated Vasculitis (CANVAS)

ANCA Associated Vasculitis | CMV Infection

United Kingdom
Washington University School of Medicine

Terminated

Trial of Preemptive Treatment With Oral Valganciclovir Compared With Intravenous (IV) Ganciclovir for Cytomegalovirus Infection After Bone Marrow or Peripheral Blood Stem Cell Transplant

Cytomegalovirus Infections

United States
Bausch & Lomb Incorporated

Completed

Corneal Endothelial Cell Density in Eyes Treated With a Fluocinolone Acetonide Intravitreal Implant

Uveitis, Posterior

United States
Hoffmann-La Roche

Completed

A Comparison of Valganciclovir and Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes

HIV Infections | Cytomegalovirus Retinitis

United States, Canada
Belfast Health and Social Care Trust
Queen's University, Belfast; Northern Ireland Clinical Trials Unit

Terminated

Epstein-Barr Virus Suppression in Chronic Obstructive Pulmonary Disease (EViSCO): a Phase 2 Randomised Control Trial (EViSCO)

COPD | EBV

United Kingdom
University Medical Center Groningen
Stanley Medical Research Institute

Completed

To Rescue Cognition With Valaciclovir

Schizophrenia | Psychosis

Netherlands
National Cancer Institute (NCI)

Completed

Bortezomib and Antiviral Therapy Followed By Effusion Drainage, Bevacizumab, and Combination Chemotherapy in Treating Patients With Primary Effusion Lymphoma

Lymphoma

United States
Neelesh Sharma MD PhD

Completed

Erlotinib Hydrochloride and Quinacrine Dihydrochloride in Stage IIIB-IV Non-Small Cell Lung Cancer

Stage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer

United States
National Institute of Allergy and Infectious Diseases...

Completed

Valganciclovir in Congenital CMV Infants

Cytomegalovirus Infections

United States
Xijing Hospital of Digestive Diseases

Completed

Primary Chemoprevention of Familial Adenomatous Polyposis With Berberine Hydrochloride

Colorectal Adenomas

China
Shenyang Sunshine Pharmaceutical Co., LTD.

Unknown

A Multi-site Bridging Study of Nalfurafine Hydrochloride Orally Disintegrating Tablet

Uremic Pruritus

China
Xijing Hospital of Digestive Diseases

Completed

A Research of Berberine Hydrochloride to Prevent Colorectal Adenomas in Patients With Previous Colorectal Cancer

Colorectal Adenomas

China
University Medical Center Groningen

Unknown

(Val)Ganciclovir TDM in Transplant Recipients

Cytomegalovirus Infections

Netherlands

Search clinical trials for: Valganciclovir Hydrochloride

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Croatia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations